Management of recurrent cervical cancer: a review of the literature

M Peiretti, I Zapardiel, V Zanagnolo, F Landoni… - Surgical oncology, 2012 - Elsevier
OBJECTIVE: The aim of this narrative review is to update the current knowledge on the
treatment of recurrent cervical cancer based on a literature review. MATERIAL AND …

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature

A Gadducci, S Cosio, P Zola, F Landoni… - International Journal of …, 2007 - ijgc.bmj.com
Epithelial ovarian cancer is the leading cause of death from gynecological cancer in the
Western countries. Approximately 20%–30% of patients with early-stage disease and 50 …

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

F Landoni, A Maneo, A Colombo, F Placa, R Milani… - The Lancet, 1997 - thelancet.com
Summary Background Stage Ib and IIa cervical carcinoma can be cured by radical surgery
or radiotherapy. These two procedures are equally effective, but differ in associated …

[HTML][HTML] The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the …

…, D Fischerova, C Haie-Meder, C Köhler, F Landoni… - Virchows Archiv, 2018 - Springer
Background: Despite significant advances in the screening, detection, and treatment of
preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in …

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

N Colombo, E Preti, F Landoni, S Carinelli… - Annals of …, 2013 - annalsofoncology.org
Endometrial cancer is the sixth most common malignancy among females worldwide with an
estimated incidence of about 288 000 new cases in the year 2008. In developed countries …

Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial

…, A Maggioni, N Hacker, F Landoni… - Journal of the …, 2005 - academic.oup.com
Background: The role of systematic aortic and pelvic lymphadenectomy in patients with
optimally debulked advanced ovarian cancer is unclear and has not been addressed by …

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Marth, F Landoni, S Mahner… - Annals of …, 2017 - annalsofoncology.org
Cervical cancer is the second most commonly diagnosed cancer and the third leading cause
of cancer death among females in less developed countries. There were an estimated 527 …

Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter …

…, F Raspagliesi, P Zola, C Mangioni, F Landoni - Journal of Clinical …, 2002 - iris.unito.it
PURPOSE: Neoadjuvant chemotherapy (NACT) and radical surgery (RS) have emerged as
a possible alternative to conventional radiation therapy (RT) in locally advanced cervical …

[HTML][HTML] Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis

…, P Benedetti Panici, T Dell'Anna, F Landoni… - British journal of …, 2006 - nature.com
No randomised trials have addressed the value of systematic aortic and pelvic
lymphadenectomy (SL) in ovarian cancer macroscopically confined to the pelvis. This study …

Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study

F Landoni, A Maneo, G Cormio, P Perego, R Milani… - Gynecologic …, 2001 - Elsevier
Objective. The objective of this study was to determine the role of the extent of the radicality
in the treatment of stage IB–IIA cervical carcinoma with respect to survival, pattern of relapse …